Paper Title

Stability Indicating Analytical Method Development and Validation for Molnupiravir in Human Plasma

Article Identifiers

Registration ID: IJNRD_218945

Published ID: IJNRD2405383

DOI: Click Here to Get

Authors

Vaibhav Vilas Narwade , Madhuri D. Game

Keywords

RP-HPLC, Molnupiravir, Method Development, Validation

Abstract

This study presents a robust and validated reverse-phase high-performance liquid chromatography (RP-HPLC) method for the quantification of Molnupiravir, an antiviral drug used in the treatment of COVID-19. The method was developed and optimized using a C18 column with a mobile phase consisting of methanol and sodium acetate buffer. System suitability tests demonstrated the appropriateness of the chromatographic system, ensuring precision, resolution, and peak symmetry. The method exhibited excellent specificity, as evidenced by the matching retention times of standard and test samples. Linearity was confirmed over a concentration range of 15-45 µg/ml, with a correlation coefficient (R²) of 0.9995. Accuracy studies revealed recoveries ranging from 99.81% to 101.91%, indicating the method's reliability. Precision assessments, including intra-day and inter-day variations, demonstrated reproducibility with %RSD values within acceptable limits. Additionally, the method showed adequate sensitivity, with limits of detection (LOD) and quantification (LOQ) of 1.04 µg/ml and 3.17 µg/ml, respectively. Robustness studies indicated that small variations in method parameters did not significantly affect assay results. Stability studies under various stress conditions demonstrated the drug's susceptibility to degradation under acidic conditions while showing stability under other conditions. Overall, the validated RP-HPLC method offers a simple, accurate, and precise means for the routine analysis of Molnupiravir, contributing to the effective management of COVID-19 treatment protocols.

How To Cite (APA)

Vaibhav Vilas Narwade & Madhuri D. Game (May-2024). Stability Indicating Analytical Method Development and Validation for Molnupiravir in Human Plasma. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(5), d739-d748. https://ijnrd.org/papers/IJNRD2405383.pdf

Issue

Volume 9 Issue 5, May-2024

Pages : d739-d748

Other Publication Details

Paper Reg. ID: IJNRD_218945

Published Paper Id: IJNRD2405383

Downloads: 000121981

Research Area: Pharmacy

Country: Hingoli, Maharashtra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2405383.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2405383

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details